A Review of Butyrylcholinesterase as a Therapeutic Target in the Treatment of Alzheimer’s Disease

Nordberg, Agneta, Ballard, Clive, Bullock, Roger, Darreh-Shori, Taher, Somogyi, Monique·2013·The Primary Care Companion For CNS Disorders
DOI 10.4088/pcc.12r01412

Cited by (351)

Items 301–351 of 351

  1. Unlocking Oceanic Treasures From Marine Metabolites as Potential Therapeutics for Neurodegenerative Diseases
    K. Sandhanam, T. Tamilanban · 2024 · Advances in medical technologies and clinical practice book series
  2. Pharmacological Interventions
    Simon Gerhand · 2024 · Cambridge University Press eBooks
  3. Development and Characterization of Nanostructured Lipid Carriers for Sustained Rivastigmine Delivery
    Shereen M. Assaf, Ayat I. Almnayyes, Rana Obaidat · 2025 · SSRN Electronic Journal
  4. Exploring thiazole based thiosemicarbazide as a potent inhibitor of acetylcholinesterase and butyrylcholinesterase enzyme and their molecular docking studies
    Muhammad Taha, Leena Sheikh, Bushra Adalat, Syahrul Imran Abu Bakar, Fazal Rahim, Muhammad Nawaz, Nizam Uddin, Khalid Mohammed Khan, Syed Adnan Alı Shah · 2025 · Pure and Applied Chemistry
  5. Additional file 1 of New 1,2,4-oxadiazole derivatives as potential multifunctional agents for the treatment of Alzheimer’s disease: design, synthesis, and biological evaluation
    Mohammed Salah Ayoup, Mariam Ghanem, Abdel-Hamid, Hamida, Marwa Muhammad Abu-Serie, Aliaa A. Masoud, Ghareeb, Doaa A., Mohammed B. Hawsawi, Amr Sayed Motawi Sonousi, Asmaa E. Kassab · 2024 · Figshare
  6. Preoperative butyrylcholinesterase activity and risk of postoperative delirium: A meta-analysis
    Yuan-Li Qiu, Cheng Song, Cui-Wan Huang, Wei-Gang Shen · 2025 · World Journal of Psychiatry
  7. Molecular Docking Study on Ciplukan Fruit (Physalis Angulata L) Using Receptor AChE for Anti-Alzheimer Agents
    Muhammad Farrel Rahadian, Ahmad Jauhari Fadillah Kusumah, Teuku Rizky Ollaf Ramadhan Syah · 2024 · Bioinformatics and Biomedical Research Journal
  8. Unveiling the bioactive potential and chemical profiling of Oenothera glazioviana extracts: chromatographic, spectrophotometric, and in silico approaches
    Milena Terzić, Güneş Ak, Kinga Kochan-Jamrozy, Magdalena Gucwa, Justyna Stefanowicz‐Hajduk, Katarzyna Turecka, Rafał Hałasa, Zoltán Cziáky, József Jekő, İsmail Şenkardeş et al. · 2026 · Food and Chemical Toxicology
  9. MULTI-PATHWAY TARGETING IN ALZHEIMER’S DISEASE: MOLECULAR DOCKING ANALYSIS OF SIX MAJOR CONSTITUENTS OF VETIVERIA ZIZANIOIDES WITH KEY RECEPTORS
    Deepali Maruti Jagdale, Swati R Dhande, Gayatri Nadar, Yashashree Sawant, Kaustubh Battellu, Sampada S. Bhosale · 2026 · INDIAN DRUGS
  10. Effects of Methanol Extract of Cratoxylum formosum (Jack) Benth. & Hook.f. ex Dyer Stem on Acetylcholinesterase Activity and Amyloid Precursor Protein metabolism in Neuronal Cells
    Ga-Eun Han, Ha-Yeon Choi, Gyeong-Min Lee, Ju-Eun Kim, Bounleuane Douangdeuane, Jae-Yoon Leem · 2026 · 생약학회지
  11. Recent Advances in Drug Development for the Management of Alzheimer’s Disease
    Amit Upadhyay, Abhishek Kumar Singh, Nandani Jayaswal, Pooja Jaiswal, S. N. Singh, Shashank Tewari · 2026 · BENTHAM SCIENCE PUBLISHERS eBooks
  12. Effectiveness of Natural Deep Eutectic Solvents (NADES) in Extracting Bioactive Compounds from Salvia sclarea : HPLC-DAD Analysis, Antioxidant and Enzymes Inhibition Potential Evaluation
    Mohammed Mansour Quradha, Mehmet Emin Duru, Selçuk Küçükaydın, Abdulkader Moqbel Farhan Qahtan, Rasool Khan, Sallah A. Al Hashedi · 2026 · ACS Omega
  13. Discovery of New Butyrylcholinesterase Inhibitors and Evaluation of Their Biological Activity against Alzheimer’s Disease
    Qinghong Liao, Xiaohan Wang, Y. B. Duan, Lina Guo, Siyu He, Weiping Lyu, Jiahe Shi, Ruihao Fu, Huachen Zhang, Yantao Han et al. · 2026 · ACS Chemical Neuroscience
  14. Oleanolic Acid Inhibits Acetylcholinesterase and Butyrylcholinesterase Through Gorge‐Dependent Allosteric Mechanisms: An Integrated Kinetic and Molecular Dynamics Study
    Ahmed M. Hakami, Fettouma Chraa, Doha EL Meskini, Hafiz Antar Makeen, Rym Hassani, Mohammed Albratty, Zia Ur Rehman, Abdelhakim Bouyahya, Tarik Aanniz · 2026 · Flavour and Fragrance Journal
  15. In Vitro Cholinesterase Inhibition and Computational Investigation of some 1,2,3‐triazole Derivatives as Dual AChE/BuChE Inhibitors
    Ayse TAN, Esra Dilek · 2026 · ChemistrySelect
  16. Chiral Sulfamoyl‐Carbamate Derivatives Bearing a Naphthalene Motif as Potent Cholinesterase Inhibitors: Synthesis, Characterization, DFT Study, Molecular Docking, and Molecular Dynamics Simulations
    Khadidja Bougheloum, Soumaya Bouskia, Chafika Bougheloum, Mourad Boukachabia, Mounia Merabet‐Khelassi · 2026 · ChemistrySelect
  17. Potential Utilization of Natural Anthraquinone Aglycone Emodin for Alzheimer's Disease: A Comprehensive Review With Computational Insights
    Salehin Sheikh, Faysal Mollah, Raihan Chowdhury, Most. Israt Jahan Oni, Mst Muslima Khatun, Md. Shadin, Md. Shimul Bhuia, Md Arshadul Hoque, Mohamed Alfaifi, Faisal H. Altemani et al. · 2026 · ChemistrySelect
  18. Beeswax Waste-Derived Pyrolysis Liquid as a Novel Multifunctional Bioactive Fraction: An Integrated Chemical and Biological Evaluation
    Abdulkadir Gül · 2026 · Food and Bioprocess Technology
  19. Machine Learning–Driven Bioprospecting of Cholinergic Medicinal Plants for Putative Leads Against Butyrylcholinesterase Towards Alzheimer’s Care
    Gideon Ampoma Gyebi, Onomeyimi O. Onesi, Saheed Sabiu · 2026 · Biochemistry Research International
  20. Light spectrum effects on huperzine A and B accumulation in axenic gametophyte cultures of Huperzia selago (L.) Bernh. ex Schrank et Mart
    Wojciech J. Szypuła, Marta Maciejczyk, Beata Wileńska · 2026 · Frontiers in Plant Science
  21. Cholinergic inputs to motoneurons in the spinal cord augment focal muscle spasticity in rodents
    Patrik Meglić, Petra Šoštarić, Eirini Tsape, Melpomeni Galani, Ana Knezović, Laura Restani, Marco Pirazzini, Ornella Rossetto, Gareth Brian Miles, Laskaro Zagoraiou et al. · 2026 · British Journal of Pharmacology
  22. BindingDB Entry 50015599: A review on ferulic acid and analogs based scaffolds for the management of Alzheimer's disease.
    BindingDB · 2023 · UC San Diego
  23. BindingDB Entry 50047275: Design, synthesis and evaluation of novel ferulic acid-memoquin hybrids as potential multifunctional agents for the treatment of Alzheimer's disease.
    BindingDB · 2017 · UC San Diego
  24. BindingDB Entry 50049120: Amino derivatives of platanic acid act as selective and potent inhibitors of butyrylcholinesterase.
    BindingDB · 2019 · UC San Diego
  25. BindingDB Entry 50001887: Tacripyrimidines, the first tacrine-dihydropyrimidine hybrids, as multi-target-directed ligands for Alzheimer's disease.
    BindingDB · 2020 · UC San Diego
  26. BindingDB Entry 50003266: Multi-target-directed ligands for treating Alzheimer's disease: Butyrylcholinesterase inhibitors displaying antioxidant and neuroprotective activities.
    BindingDB · 2020 · UC San Diego
  27. BindingDB Entry 50047319: Discovery of Highly Selective and Nanomolar Carbamate-Based Butyrylcholinesterase Inhibitors by Rational Investigation into Their Inhibition Mode.
    BindingDB · 2017 · UC San Diego
  28. BindingDB Entry 50007389: Multi-target-directed-ligands acting as enzyme inhibitors and receptor ligands.
    BindingDB · 2021 · UC San Diego
  29. BindingDB Entry 50011384: TBA
    BindingDB · 2022 · UC San Diego
  30. BindingDB Entry 50000270: Structure-Activity Relationships and Computational Investigations into the Development of Potent and Balanced Dual-Acting Butyrylcholinesterase Inhibitors and Human Cannabinoid Receptor 2 Ligands with Pro-Cognitive in Vivo Profiles.
    BindingDB · 2019 · UC San Diego
  31. BindingDB Entry 50008501: 1-Benzylpyrrolidine-3-amine-based BuChE inhibitors with anti-aggregating, antioxidant and metal-chelating properties as multifunctional agents against Alzheimer's disease.
    BindingDB · 2021 · UC San Diego
  32. BindingDB Entry 50013954: Design and synthesis of garlic-related unsymmetrical thiosulfonates as potential Alzheimer's disease therapeutics: In vitro and in silico study.
    BindingDB · 2022 · UC San Diego
  33. BindingDB Entry 50010733: Aromatic Esters of the Crinane Amaryllidaceae Alkaloid Ambelline as Selective Inhibitors of Butyrylcholinesterase.
    BindingDB · 2021 · UC San Diego
  34. BindingDB Entry 50012362: Discovery of a Potent Dual Inhibitor of Acetylcholinesterase and Butyrylcholinesterase with Antioxidant Activity that Alleviates Alzheimer-like Pathology in Old APP/PS1 Mice.
    BindingDB · 2022 · UC San Diego
  35. BindingDB Entry 50013955: Huprine Y - Tryptophan heterodimers with potential implication to Alzheimer's disease treatment.
    BindingDB · 2022 · UC San Diego
  36. BindingDB Entry 50001419: Nature-based molecules combined with rivastigmine: A symbiotic approach for the synthesis of new agents against Alzheimer's disease.
    BindingDB · 2020 · UC San Diego
  37. BindingDB Entry 50007333: Isoquinoline Alkaloids from Berberis vulgaris as Potential Lead Compounds for the Treatment of Alzheimer's Disease.
    BindingDB · 2021 · UC San Diego
  38. BindingDB Entry 50002429: The concept of hybrid molecules of tacrine and benzyl quinolone carboxylic acid (BQCA) as multifunctional agents for Alzheimer's disease.
    BindingDB · 2020 · UC San Diego
  39. BindingDB Entry 50046826: Tacrine-Trolox Hybrids: A Novel Class of Centrally Active, Nonhepatotoxic Multi-Target-Directed Ligands Exerting Anticholinesterase and Antioxidant Activities with Low In Vivo Toxicity.
    BindingDB · 2016 · UC San Diego
  40. BindingDB Entry 50022809: Chromenone: An emerging scaffold in anti-Alzheimer drug discovery.
    BindingDB · 2026 · UC San Diego
  41. BindingDB Entry 50013172: Discovery of new phenyl sulfonyl-pyrimidine carboxylate derivatives as the potential multi-target drugs with effective anti-Alzheimer's action: Design, synthesis, crystal structure and in-vitro biological evaluation.
    BindingDB · 2022 · UC San Diego
  42. BindingDB Entry 50014707: Discovery of 1-(phenylsulfonyl)-1H-indole-based multifunctional ligands targeting cholinesterases and 5-HT
    BindingDB · 2022 · UC San Diego
  43. BindingDB Entry 50007930: Dual-Acting Cholinesterase-Human Cannabinoid Receptor 2 Ligands Show Pronounced Neuroprotection in Vitro and Overadditive and Disease-Modifying Neuroprotective Effects in Vivo.
    BindingDB · 2021 · UC San Diego
  44. BindingDB Entry 50008884: Design, biological evaluation and X-ray crystallography of nanomolar multifunctional ligands targeting simultaneously acetylcholinesterase and glycogen synthase kinase-3.
    BindingDB · 2021 · UC San Diego
  45. BindingDB Entry 50017722: From tryptophan-based amides to tertiary amines: Optimization of a butyrylcholinesterase inhibitor series.
    BindingDB · 2023 · UC San Diego
  46. BindingDB Entry 50022005: Enhanced Recognition Memory through Dual Modulation of Brain Carbonic Anhydrases and Cholinesterases.
    BindingDB · 2025 · UC San Diego
  47. BindingDB Entry 50044755: Multitarget drug design strategy: quinone-tacrine hybrids designed to block amyloid-ß aggregation and to exert anticholinesterase and antioxidant effects.
    BindingDB · 2016 · UC San Diego
  48. BindingDB Entry 50000730: Novel tacrine-1,2,3-triazole hybrids: In vitro, in vivo biological evaluation and docking study of cholinesterase inhibitors.
    BindingDB · 2020 · UC San Diego
  49. BindingDB Entry 50007468: Tackling neuroinflammation and cholinergic deficit in Alzheimer's disease: Multi-target inhibitors of cholinesterases, cyclooxygenase-2 and 15-lipoxygenase.
    BindingDB · 2021 · UC San Diego
  50. BindingDB Entry 50012241: Discovery of novel berberine derivatives with balanced cholinesterase and prolyl oligopeptidase inhibition profile.
    BindingDB · 2022 · UC San Diego
  51. BindingDB Entry 50020080: Highly efficient, catalyst-free, one-pot sequential four-component synthesis of novel spiroindolinone-pyrazole scaffolds as anti-Alzheimer agents:
    BindingDB · 2024 · UC San Diego